Needham downgraded Cara Therapeutics from Buy to Hold
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/13/2024 | $6.00 → $1.00 | Buy → Hold | Stifel |
| 6/13/2024 | $10.00 → $1.00 | Buy → Hold | Canaccord Genuity |
| 6/13/2024 | Buy → Hold | Needham | |
| 6/13/2024 | Buy → Neutral | H.C. Wainwright | |
| 3/8/2023 | $13.00 → $6.00 | Neutral → Underperform | BofA Securities |
| 3/8/2022 | $17.00 → $20.00 | Neutral → Overweight | JP Morgan |
| 11/1/2021 | $33.00 | Buy | Canaccord Genuity |
| 8/24/2021 | $33.00 → $35.00 | Buy | HC Wainwright & Co. |